Congress highlights

Highlights from meetings and congresses on endometriosis


ASRM2017: progress in endometriosis, but a vital step is missing
9 November 2017

At ASRM2017 it was apparent that true research progress will not happen until sub-groups (phenotypes) of endometriosis are identified.

ESHRE2017: Endometriosis highlights
6 July 2017

Endometriosis sessions at ESHRE’s 33rd Annual Scientific Meeting were better attended than ever – and were all about finding the balance between medical and surgical therapies for the individual woman.

ESHRE2017: Measuring and enhancing endometrial receptivity to improve pregnancy outcomes
4 July 2017

Packed endometriosis special interest group pre-congress course at ESHRE in Geneva.

World Congress on Endometriosis empowers women through advocacy and education
1 June 2017

When like-minded individuals come together with a selfless, common, goal to champion the cause, we can truly lead positive change in the field of endometriosis.

WCE2017: Phase III data for elagolix shows potential as treatment for endometriosis
19 May 2017

Efficacy and safety of two different doses of elagolix, a GnRH antagonist, presented at World Congress on Endometrosis.

WCE2017: Women with endometriosis drive research priorities
19 May 2017

Top ten research priorities in endometriosis presented at 13th World Congress on Endometriosis.

WCE2017: H2Oil study confirms significant fertility benefit from Lipiodol
18 May 2017

100-year-old fertility technique could reduce IVF cases in women with endometriosis.

ASRM2015: Endometriosis highlights
26 October 2015

Chair-elect of the ASRM Endometriosis Special Interest Group, Doctor Stacey Missmer, provides highlights from this year’s annual meeting. There is no size that fits all – think symptoms and think endometrium behaviour!

ASRM2015: Endometriosis may infiltrate the entire body
20 October 2015

Study suggests that endometriosis in organs outside of the pelvis may be common and clinically unrecognised.

ASRM2015: Increased risk of ovarian cancer observed in women undergoing IVF
20 October 2015

Increased risk of ovarian cancer observed in women who had no children following assisted reproductive technologies, and in women with endometriosis treated for infertility.

Stay up to date

Register for endometriosis news:

Connect

Twitter Follow us on Twitter
  • RT @horne_research: Read our Lancet article highlighting the importance of doctors communicating effectively the low increase in risk of ov…

Get involved

Help us improve treatments for endometriosis and prevent this disease in the next generation of women. Support the work of the World Endometriosis Research Foundation.

Donate to research Shop for WERF Volunteer